VIRTUS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Sept 2023)
What this means for you
Registered since 03 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86587871
- Registration number
- 5111954
- Mark type
- Stylized text
- Filed
- 06 Apr 2015
- Published for opposition
- 18 Oct 2016
- Registered
- 03 Jan 2017
- Attorney of record
- Laurence Tauber
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, prescription and over-the-counter drugs for the treatment of illness, disease or deficiencies, namely, bacterial infections, treatment symptoms of seasonal, perennial and chronic allergies and the treatment of skin hives and itching associated with skin reactions, Type 2 diabetes mellitus, Treatment and prevention of osteoporosis in postmenopausal women, treatment to increase bone mass in men with osteoporosis, treatment of glucocorticoid induced osteoporosis, Treatment of Paget's Disease of bone, Treatment for the relief of discomfort associated with acute or painful musculoskeletal conditions, Treatment and management of moderate to moderately-severe pain in adults, Treatment of hypertension, Treatment of diabetic nephropathy, Treatment of dermatitis herpetiformis and leprosy, Treatment of chronic inflammatory skin disease marked by blisters, Treatment of acid indigestion, Treatment of upset stomach, Management and support for patients requiring increased folate levels, Supplementation in support of bone health, Supplementation in support of prenatal health, including, without limitation, increased folic acid, Management and support of absorption of calcium and/or functioning of calcium in the body, Treatment of Vitamin D deficiency, Supplementation in support of postnatal health, Treatment and prevention of lack of vitamins, minerals and/or fatty acids during pregnancy, Treatment and temporary relief of cough, nasal congestion, loosening of phlegm and thin bronchial secretions, Treatment and prevention of prenatal and postnatal folate deficiency, Treatment of elevated or high levels of uric acid and prevention and treatment of metabolic problems caused by kidney disease, prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets, hormone replacement therapy, Postnatal supplementation and improvement of nutritional states of women prior to conception, prevention of acidosis, stomach or bowel problems, peptic ulcers and irritable bowel syndrome, Treatment for excessive saliva production, irritable colon and bladder dysfunction, Treatment of symptoms associated with disorders of gastrointestinal tract, bladder spasms, peptic ulcer disease, diverticulitis, irritable bowel syndrome, cystitis and pancreatitis, Prevention and treatment of low blood levels of potassium, Prevention of Fetal Neural Tube Defects when pregnant, Treatment of inadequate folic acid, folate deficiency, and anemia from inadequate folic acid, Treatment of Hyperhomocysteinemia
- Class 035 — Advertising and business services: Distributorship services in the field of prescription and over-the-counter drugs; marketing of prescription and over-the-counter drugs
- Class 042 — Scientific and technological services: Development of pharmaceutical products
Owner
- Virtus Pharmaceuticals, LLC, Newtown, PA, US
- Virtus Pharmaceuticals, LLC, Tampa, FL, US
- Virtus Pharmaceuticals, LLC, Tampa, FL, US
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Sept 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Mar 2023 — TEAS SECTION 8 & 15 RECEIVED
- 03 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Jan 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 11 Jan 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 03 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 18 Oct 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Oct 2016 — PUBLISHED FOR OPPOSITION
- 28 Sept 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Sept 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 01 Sept 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Aug 2016 — EXAMINER'S AMENDMENT ENTERED